SCHEMBL4086547

SCHEMBL4086547

CCOC(=O)c1cc2sc(-c3ccc(OC(C)C)cc3)cc2n1-c1ccc(OC(C)C)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.46
ALDH1A1 P00352 6/20 0.46
KDM4E B2RXH2 5/20 0.46
NPC1 O15118 5/20 0.46
RAB9A P51151 5/20 0.46
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
HSD17B10 Q99714 4/20 0.46
HPGD P15428 3/20 0.46
TP53 P04637 2/20 0.46
CASP3 P42574 1/20 0.46
SENP8 Q96LD8 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
SENP6 Q9GZR1 1/20 0.46
TSHR P16473 3/20 0.44
PTGES O14684 2/20 0.44
PPARG P37231 2/20 0.42
NCOA2 Q15596 2/20 0.42
NCOA1 Q15788 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4097942 0.86 PTGES (0.57) ALDH1A1KMT2ATSHRPTGESPKM
SCHEMBL3575712 0.82 PTGES (0.64) MAPTALDH1A1KDM4ENPC1RAB9A
SCHEMBL5265086 0.80 NOD2 (0.49) MAPTALDH1A1KDM4ENPC1MEN1
SCHEMBL3571774 0.78 PTGES (0.43) MAPTALDH1A1KDM4ENPC1RAB9A
SCHEMBL4096225 0.78 PTGES (0.54) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL3581409 0.78 PTGES (0.59) MAPTALDH1A1KDM4EKMT2APTGES
SCHEMBL3001458 0.78 PTGES (0.51) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL4917266 0.78 PTGES (0.44) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL4920933 0.78 PTGES (0.48) MAPTTP53PTGESSMN1; SMN2GAA
SCHEMBL4101700 0.77 PTGES (0.48) KDM4ENPC1PTGES

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090069384-A1 THIENOPYRROLES USEFUL IN THE TREATMENT OF INFLAMMATION BIOLIPOX AB (SE) 2009-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069384-A1 THIENOPYRROLES USEFUL IN THE TREATMENT OF INFLAMMATION NPY5R, TH, PTGES MAPT 54/4885ALDH1A1 2718/4885KDM4E 583/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.